Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PHYSICIANS LABORATORIES OF AMERICA

NPI: 1790024131 · LITTLE ROCK, AR 72205 · Clinical Medical Laboratory · NPI assigned 02/05/2013

$663K
Total Medicaid Paid
62,861
Total Claims
53,376
Beneficiaries
26
Codes Billed
2019-02
First Month
2024-12
Last Month

Provider Details

Authorized OfficialRICHMOND, JANET (MANAGER)
NPI Enumeration Date02/05/2013

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 14,160 $170K
2020 10,564 $103K
2021 11,007 $101K
2022 6,922 $56K
2023 7,262 $86K
2024 12,946 $147K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80356 3,487 2,925 $54K
80361 3,423 2,895 $50K
80346 3,439 2,893 $44K
80348 3,374 2,837 $42K
80354 3,424 2,882 $40K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,567 1,372 $39K
80358 3,350 2,834 $38K
80365 3,350 2,852 $36K
80324 3,491 2,924 $35K
80353 3,464 2,909 $31K
80372 3,392 2,875 $31K
80359 3,419 2,877 $28K
80369 3,177 2,704 $28K
80357 3,173 2,685 $27K
80373 3,336 2,844 $27K
80363 2,127 1,860 $22K
80367 2,236 1,960 $17K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 547 530 $16K
80349 1,778 1,474 $15K
83992 3,372 2,857 $14K
80362 883 703 $11K
80368 2,132 1,867 $8K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 279 267 $7K
80355 331 257 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 220 218 $632.83
80320 90 75 $178.42